Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Liver transplantation is the only effective therapeutic option for patients with end-stage liver disease due to primary sclerosing cholangitis (PSC). In this study, we analyzed a single center's experience with 150 consecutive PSC patients who received 174 liver allografts. Mean follow-up was 55 months. Actuarial patient survival at 1, 2, 5, and 10 years was 93.7%, 92.2%, 86.4%, and 69.8%, respectively, whereas graft survival was 83.4%, 83.4%, 79.0%, and 60.5%, respectively. The main indication for retransplantation was hepatic artery thrombosis, and the major cause of death was severe infection. Patients with PSC had a higher incidence of acute cellular and chronic ductopenic rejection compared to a non-PSC control group. Chronic ductopenic rejection adversely affected patient and graft survival. Biliary strictures, both anastomotic and nonanastomotic, were frequent and occurred in 16.2% and 27.2% of patients, respectively. The incidence of recurrent PSC was 20%. A negative impact on patient survival was not seen in patients with either postoperative biliary strictures or recurrence of PSC. Six patients (4%) had cholangiocarcinoma and 1 patient died related to recurrence of malignant disease. Seventy-eight percent of PSC patients had associated inflammatory bowel disease, most commonly chronic ulcerative colitis, which did not adversely impact patient outcome posttransplantation. Nine patients required proctocolectomy after liver transplantation; 5 because of intractable symptoms related to inflammatory bowel disease and 4 due to the development of colorectal carcinoma/high-grade dysplasia. Our data show that liver transplantation provides excellent long-term patient and graft survival for patients with end-stage PSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapman, R. W., Arborgh, B. A., Rhodes, J. M., Summerfield, J. A., Dick, R., Scheuer, P. J., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.10.870 · Cited by 732
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
Self-citationPrimary Sclerosing Cholangitis
Lee, Y.-M., & Kaplan, M. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321406 · Cited by 526
Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †
Wiesner, R. H., Demetris, J. A., Belle, S. H., Seaberg, E. C., Lake, J. R., Zetterman, R. K., Everhart, J., & Detre, K. M. (1998) · Hepatology · doi:10.1002/hep.510280306 · Cited by 495
Self-citationSchiff's diseases of the liver
HERRINE, S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70521-4 · Cited by 440
Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis
ROSEN, C. B., NAGORNEY, D. M., WIESNER, R. H., COFFEY, R. J., & LARUSSO, N. F. (1991) · Annals of Surgery · doi:10.1097/00000658-199101000-00004 · Cited by 391
Self-citationRecurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
Graziadei, I. W., Wiesner, R. H., Batts, K. P., Marotta, P. J., LaRusso, N. F., Porayko, M. K., Hay, E. J., Gores, G. J., Charlton, M. R., Ludwig, J., et al. (1999) · Hepatology · doi:10.1002/hep.510290427 · Cited by 375
Self-citationBrentnall, T., Haggitt, R., Rabinovitch, P., Kimmey, M., Bronner, M., Levine, D., Kowdley, K., Stevens, A., Crispin, D., Emond, M., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566577 · Cited by 337
Goss, J. A., Shackleton, C. R., Farmer, D. G., Arnaout, W. S., Seu, P., Markowitz, J. S., Martin, P., Stribling, R. J., Goldstein, L. I., & Busuttil, R. W. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00004 · Cited by 328
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis
MARSH, J. W., IWATSUKI, S., MAKOWKA, L., ESQUIVEL, C. O., GORDON, R. D., TODO, S., TZAKIS, A., MILLER, C., THIEL, D. V., & STARZL, T. E. (1988) · Annals of Surgery · doi:10.1097/00000658-198801000-00005 · Cited by 253
Cited by
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Self-citationAASLD practice guidelines: Evaluation of the patient for liver transplantation†
Murray, K. F., & Carithers, R. L. (2005) · Hepatology · doi:10.1002/hep.20704 · Cited by 939
MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A. F., & Kim, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25879 · Cited by 864
Self-citationPrimary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Bambha, K., Kim, W. R., Talwalkar, J., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., & Melton, L. J. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.011 · Cited by 450
Graziadei, I. W., Sandmueller, H., Waldenberger, P., Koenigsrainer, A., Nachbaur, K., Jaschke, W., Margreiter, R., & Vogel, W. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50106 · Cited by 439
Self-citationPathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.052 · Cited by 436
Self-citationTischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413
Epidemiology of cholangiocarcinoma
Bergquist, A., & von Seth, E. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.02.003 · Cited by 400
Liver biopsy interpretation for causes of late liver allograft dysfunction
(2006) · Hepatology · doi:10.1002/hep.21280 · Cited by 359
Primary Sclerosing Cholangitis in Children: A Long–Term Follow–Up Study
Feldstein, A. E., Perrault, J., El-Youssif, M., Lindor, K. D., Freese, D. K., & Angulo, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50289 · Cited by 256
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
Small-duct primary sclerosing cholangitis: a long-term follow-up study
Angulo, P., Maor-Kendler, Y., & Lindor, K. D. (2002) · Hepatology · doi:10.1053/jhep.2002.33202 · Cited by 213
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Ravikumar, R., Tsochatzis, E., Jose, S., Allison, M., Athale, A., Creamer, F., Gunson, B., Iyer, V., Madanur, M., Manas, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.005 · Cited by 173
Fevery, J., Verslype, C., Lai, G., Aerts, R., & Van Steenbergen, W. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9681-4 · Cited by 145
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis
Triantos, C. K., Koukias, N. M., Nikolopoulou, V. N., & Burroughs, A. K. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04822.x · Cited by 132
Primary sclerosing cholangitis: diagnosis, prognosis, and management
Singh, S., & Talwalkar, J. A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.016 · Cited by 119
Joshi, D., Bjarnason, I., Belgaumkar, A., O'Grady, J., Suddle, A., Heneghan, M. A., Aluvihare, V., Rela, M., Heaton, N., & Agarwal, K. (2013) · Liver International · doi:10.1111/j.1478-3231.2011.02677.x · Cited by 99
Brandsæter, B., Broomé, U., Isoniemi, H., Friman, S., Hansen, B., Schrumpf, E., Oksanen, A., Ericzon, B.-G., Höckerstedt, K., Mäkisalo, H., et al. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50169 · Cited by 71
“6 (1-34) Creatinine in mol/L, mean/median (range) 82/75 (30-497) 80/74 (30-262) 85/76 (41-497) Creatinine 150 mol/L (%) 9 (4) 4 (3) 5 (4) Bilirubin in mol/L, mean/median (range) 176/121 (6-787) 199/143 (9-620) 157/103 (6-787)‡ Bilirubin 150 mol/L (%) 112 (44) 54 (47) 58 (42) Albumin in g/L, mean/median (range) 28/28 (…”
Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis
Levy, C., & Martin, E. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1608655 · Cited by 46
Peverelle, M., Paleri, S., Hughes, J., De Cruz, P., & Gow, P. J. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz325 · Cited by 47
Metadata
- Authors
- Graziadei, I. W., Wiesner, R. H., Marotta, P. J., Porayko, M. K., Hay, E. J., Charlton, M. R., Poterucha, J. J., Rosen, C. B., Gores, G. J., LaRusso, N. F., & Krom, R. A. F.
- Venue
- Hepatology
- Published
- 1999-11
- Volume
- 30
- Issue
- 5
- Pages
- 1121-1127
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1976730200
- Cited by
- 359
- References
- 40
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.